Lichen Sclerosus Treatment Market - Global Outlook and Forecast 2022-2028

March 2022 | 63 pages | ID: L7EB2CB2294AEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Lichen sclerosus is a chronic disorder of the skin, affecting the genital and anal areas. However, in some serious cases, they may appear on upper body such as arms and breast regions. According to various studies, lichen sclerosus is most common in females (after menopause), uncommon in adult males, and very rare in children. Lichen sclerosus appears by forming white spots on the affected regions, the spots may be glossy and smooth in appearance, if untreated they develop into bigger patches. In addition, lichen sclerosus may result in red or purple colored bruises, skin becomes more prone to tear, itching and bleeding. The main cause of lichen sclerosus is still unknown, it is believed to be caused by hyper-immunity reactions or by hormonal imbalance. An individual with previous skin destruction around genital or anal region, are more susceptible to develop lichen sclerosus. Corticosteroids are mainly used for the treatment and management of lichen sclerosus. Women with vulva’s lichen sclerosus are at a high risk of causing vulvar cancer.

This report contains market size and forecasts of Lichen Sclerosus Treatment in Global, including the following market information:

Global Lichen Sclerosus Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Lichen Sclerosus Treatment market was valued at 97 million in 2021 and is projected to reach US$ 129.5 million by 2028, at a CAGR of 4.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Topical Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Lichen Sclerosus Treatment include GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer, AstraZeneca, Sandoz AG (Novartis AG), Sanofi S.A, Bristol-Myers Squibb Company and Bausch Health and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lichen Sclerosus Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Lichen Sclerosus Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Lichen Sclerosus Treatment Market Segment Percentages, by Type, 2021 (%)
  • Topical
  • Oral
  • Injection
  • Others
Global Lichen Sclerosus Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Lichen Sclerosus Treatment Market Segment Percentages, by Application, 2021 (%)
  • Hospital Pharmacies
  • Clinics
  • Retail Pharmacies
  • Online Pharmacies
  • Others
Global Lichen Sclerosus Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Lichen Sclerosus Treatment Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Lichen Sclerosus Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Lichen Sclerosus Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck
  • Pfizer
  • AstraZeneca
  • Sandoz AG (Novartis AG)
  • Sanofi S.A
  • Bristol-Myers Squibb Company
  • Bausch Health
  • Zylera Pharmaceuticals
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Lichen Sclerosus Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Lichen Sclerosus Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LICHEN SCLEROSUS TREATMENT OVERALL MARKET SIZE

2.1 Global Lichen Sclerosus Treatment Market Size: 2021 VS 2028
2.2 Global Lichen Sclerosus Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Lichen Sclerosus Treatment Players in Global Market
3.2 Top Global Lichen Sclerosus Treatment Companies Ranked by Revenue
3.3 Global Lichen Sclerosus Treatment Revenue by Companies
3.4 Top 3 and Top 5 Lichen Sclerosus Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Lichen Sclerosus Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lichen Sclerosus Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Lichen Sclerosus Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Lichen Sclerosus Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Lichen Sclerosus Treatment Market Size Markets, 2021 & 2028
  4.1.2 Topical
  4.1.3 Oral
  4.1.4 Injection
  4.1.5 Others
4.2 By Type - Global Lichen Sclerosus Treatment Revenue & Forecasts
  4.2.1 By Type - Global Lichen Sclerosus Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Lichen Sclerosus Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Lichen Sclerosus Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Lichen Sclerosus Treatment Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Clinics
  5.1.4 Retail Pharmacies
  5.1.5 Online Pharmacies
  5.1.6 Others
5.2 By Application - Global Lichen Sclerosus Treatment Revenue & Forecasts
  5.2.1 By Application - Global Lichen Sclerosus Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Lichen Sclerosus Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Lichen Sclerosus Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Lichen Sclerosus Treatment Market Size, 2021 & 2028
6.2 By Region - Global Lichen Sclerosus Treatment Revenue & Forecasts
  6.2.1 By Region - Global Lichen Sclerosus Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Lichen Sclerosus Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Lichen Sclerosus Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Lichen Sclerosus Treatment Revenue, 2017-2028
  6.3.2 US Lichen Sclerosus Treatment Market Size, 2017-2028
  6.3.3 Canada Lichen Sclerosus Treatment Market Size, 2017-2028
  6.3.4 Mexico Lichen Sclerosus Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Lichen Sclerosus Treatment Revenue, 2017-2028
  6.4.2 Germany Lichen Sclerosus Treatment Market Size, 2017-2028
  6.4.3 France Lichen Sclerosus Treatment Market Size, 2017-2028
  6.4.4 U.K. Lichen Sclerosus Treatment Market Size, 2017-2028
  6.4.5 Italy Lichen Sclerosus Treatment Market Size, 2017-2028
  6.4.6 Russia Lichen Sclerosus Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Lichen Sclerosus Treatment Market Size, 2017-2028
  6.4.8 Benelux Lichen Sclerosus Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Lichen Sclerosus Treatment Revenue, 2017-2028
  6.5.2 China Lichen Sclerosus Treatment Market Size, 2017-2028
  6.5.3 Japan Lichen Sclerosus Treatment Market Size, 2017-2028
  6.5.4 South Korea Lichen Sclerosus Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Lichen Sclerosus Treatment Market Size, 2017-2028
  6.5.6 India Lichen Sclerosus Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Lichen Sclerosus Treatment Revenue, 2017-2028
  6.6.2 Brazil Lichen Sclerosus Treatment Market Size, 2017-2028
  6.6.3 Argentina Lichen Sclerosus Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Lichen Sclerosus Treatment Revenue, 2017-2028
  6.7.2 Turkey Lichen Sclerosus Treatment Market Size, 2017-2028
  6.7.3 Israel Lichen Sclerosus Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Lichen Sclerosus Treatment Market Size, 2017-2028
  6.7.5 UAE Lichen Sclerosus Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 GlaxoSmithKline
  7.1.1 GlaxoSmithKline Corporate Summary
  7.1.2 GlaxoSmithKline Business Overview
  7.1.3 GlaxoSmithKline Lichen Sclerosus Treatment Major Product Offerings
  7.1.4 GlaxoSmithKline Lichen Sclerosus Treatment Revenue in Global Market (2017-2022)
  7.1.5 GlaxoSmithKline Key News
7.2 Johnson & Johnson
  7.2.1 Johnson & Johnson Corporate Summary
  7.2.2 Johnson & Johnson Business Overview
  7.2.3 Johnson & Johnson Lichen Sclerosus Treatment Major Product Offerings
  7.2.4 Johnson & Johnson Lichen Sclerosus Treatment Revenue in Global Market (2017-2022)
  7.2.5 Johnson & Johnson Key News
7.3 Merck
  7.3.1 Merck Corporate Summary
  7.3.2 Merck Business Overview
  7.3.3 Merck Lichen Sclerosus Treatment Major Product Offerings
  7.3.4 Merck Lichen Sclerosus Treatment Revenue in Global Market (2017-2022)
  7.3.5 Merck Key News
7.4 Pfizer
  7.4.1 Pfizer Corporate Summary
  7.4.2 Pfizer Business Overview
  7.4.3 Pfizer Lichen Sclerosus Treatment Major Product Offerings
  7.4.4 Pfizer Lichen Sclerosus Treatment Revenue in Global Market (2017-2022)
  7.4.5 Pfizer Key News
7.5 AstraZeneca
  7.5.1 AstraZeneca Corporate Summary
  7.5.2 AstraZeneca Business Overview
  7.5.3 AstraZeneca Lichen Sclerosus Treatment Major Product Offerings
  7.5.4 AstraZeneca Lichen Sclerosus Treatment Revenue in Global Market (2017-2022)
  7.5.5 AstraZeneca Key News
7.6 Sandoz AG (Novartis AG)
  7.6.1 Sandoz AG (Novartis AG) Corporate Summary
  7.6.2 Sandoz AG (Novartis AG) Business Overview
  7.6.3 Sandoz AG (Novartis AG) Lichen Sclerosus Treatment Major Product Offerings
  7.6.4 Sandoz AG (Novartis AG) Lichen Sclerosus Treatment Revenue in Global Market (2017-2022)
  7.6.5 Sandoz AG (Novartis AG) Key News
7.7 Sanofi S.A
  7.7.1 Sanofi S.A Corporate Summary
  7.7.2 Sanofi S.A Business Overview
  7.7.3 Sanofi S.A Lichen Sclerosus Treatment Major Product Offerings
  7.7.4 Sanofi S.A Lichen Sclerosus Treatment Revenue in Global Market (2017-2022)
  7.7.5 Sanofi S.A Key News
7.8 Bristol-Myers Squibb Company
  7.8.1 Bristol-Myers Squibb Company Corporate Summary
  7.8.2 Bristol-Myers Squibb Company Business Overview
  7.8.3 Bristol-Myers Squibb Company Lichen Sclerosus Treatment Major Product Offerings
  7.8.4 Bristol-Myers Squibb Company Lichen Sclerosus Treatment Revenue in Global Market (2017-2022)
  7.8.5 Bristol-Myers Squibb Company Key News
7.9 Bausch Health
  7.9.1 Bausch Health Corporate Summary
  7.9.2 Bausch Health Business Overview
  7.9.3 Bausch Health Lichen Sclerosus Treatment Major Product Offerings
  7.9.4 Bausch Health Lichen Sclerosus Treatment Revenue in Global Market (2017-2022)
  7.9.5 Bausch Health Key News
7.10 Zylera Pharmaceuticals
  7.10.1 Zylera Pharmaceuticals Corporate Summary
  7.10.2 Zylera Pharmaceuticals Business Overview
  7.10.3 Zylera Pharmaceuticals Lichen Sclerosus Treatment Major Product Offerings
  7.10.4 Zylera Pharmaceuticals Lichen Sclerosus Treatment Revenue in Global Market (2017-2022)
  7.10.5 Zylera Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES

Table 1. Lichen Sclerosus Treatment Market Opportunities & Trends in Global Market
Table 2. Lichen Sclerosus Treatment Market Drivers in Global Market
Table 3. Lichen Sclerosus Treatment Market Restraints in Global Market
Table 4. Key Players of Lichen Sclerosus Treatment in Global Market
Table 5. Top Lichen Sclerosus Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Lichen Sclerosus Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Lichen Sclerosus Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Lichen Sclerosus Treatment Product Type
Table 9. List of Global Tier 1 Lichen Sclerosus Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lichen Sclerosus Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Lichen Sclerosus Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Lichen Sclerosus Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Lichen Sclerosus Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Lichen Sclerosus Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Lichen Sclerosus Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Lichen Sclerosus Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Lichen Sclerosus Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Lichen Sclerosus Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Lichen Sclerosus Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Lichen Sclerosus Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Lichen Sclerosus Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Lichen Sclerosus Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Lichen Sclerosus Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Lichen Sclerosus Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Lichen Sclerosus Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Lichen Sclerosus Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Lichen Sclerosus Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Lichen Sclerosus Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Lichen Sclerosus Treatment Revenue, (US$, Mn), 2023-2028
Table 30. GlaxoSmithKline Corporate Summary
Table 31. GlaxoSmithKline Lichen Sclerosus Treatment Product Offerings
Table 32. GlaxoSmithKline Lichen Sclerosus Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Johnson & Johnson Corporate Summary
Table 34. Johnson & Johnson Lichen Sclerosus Treatment Product Offerings
Table 35. Johnson & Johnson Lichen Sclerosus Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Merck Corporate Summary
Table 37. Merck Lichen Sclerosus Treatment Product Offerings
Table 38. Merck Lichen Sclerosus Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer Corporate Summary
Table 40. Pfizer Lichen Sclerosus Treatment Product Offerings
Table 41. Pfizer Lichen Sclerosus Treatment Revenue (US$, Mn), (2017-2022)
Table 42. AstraZeneca Corporate Summary
Table 43. AstraZeneca Lichen Sclerosus Treatment Product Offerings
Table 44. AstraZeneca Lichen Sclerosus Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Sandoz AG (Novartis AG) Corporate Summary
Table 46. Sandoz AG (Novartis AG) Lichen Sclerosus Treatment Product Offerings
Table 47. Sandoz AG (Novartis AG) Lichen Sclerosus Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Sanofi S.A Corporate Summary
Table 49. Sanofi S.A Lichen Sclerosus Treatment Product Offerings
Table 50. Sanofi S.A Lichen Sclerosus Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Bristol-Myers Squibb Company Corporate Summary
Table 52. Bristol-Myers Squibb Company Lichen Sclerosus Treatment Product Offerings
Table 53. Bristol-Myers Squibb Company Lichen Sclerosus Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Bausch Health Corporate Summary
Table 55. Bausch Health Lichen Sclerosus Treatment Product Offerings
Table 56. Bausch Health Lichen Sclerosus Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Zylera Pharmaceuticals Corporate Summary
Table 58. Zylera Pharmaceuticals Lichen Sclerosus Treatment Product Offerings
Table 59. Zylera Pharmaceuticals Lichen Sclerosus Treatment Revenue (US$, Mn), (2017-2022)

LIST OF FIGURES

Figure 1. Lichen Sclerosus Treatment Segment by Type in 2021
Figure 2. Lichen Sclerosus Treatment Segment by Application in 2021
Figure 3. Global Lichen Sclerosus Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Lichen Sclerosus Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Lichen Sclerosus Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lichen Sclerosus Treatment Revenue in 2021
Figure 8. By Type - Global Lichen Sclerosus Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Lichen Sclerosus Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Lichen Sclerosus Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Lichen Sclerosus Treatment Revenue Market Share, 2017-2028
Figure 12. US Lichen Sclerosus Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Lichen Sclerosus Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Lichen Sclerosus Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Lichen Sclerosus Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Lichen Sclerosus Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Lichen Sclerosus Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Lichen Sclerosus Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Lichen Sclerosus Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Lichen Sclerosus Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Lichen Sclerosus Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Lichen Sclerosus Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Lichen Sclerosus Treatment Revenue Market Share, 2017-2028
Figure 24. China Lichen Sclerosus Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Lichen Sclerosus Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Lichen Sclerosus Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Lichen Sclerosus Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Lichen Sclerosus Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Lichen Sclerosus Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Lichen Sclerosus Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Lichen Sclerosus Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Lichen Sclerosus Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Lichen Sclerosus Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Lichen Sclerosus Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Lichen Sclerosus Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Lichen Sclerosus Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. GlaxoSmithKline Lichen Sclerosus Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Johnson & Johnson Lichen Sclerosus Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Merck Lichen Sclerosus Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer Lichen Sclerosus Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. AstraZeneca Lichen Sclerosus Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sandoz AG (Novartis AG) Lichen Sclerosus Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sanofi S.A Lichen Sclerosus Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bristol-Myers Squibb Company Lichen Sclerosus Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bausch Health Lichen Sclerosus Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Zylera Pharmaceuticals Lichen Sclerosus Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)



More Publications